| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | Director | Common Stock | 4,591 | $133,139 | $29.00 | 12 Jun 2025 | Direct |
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | 18 Sep 2024 | Direct |
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15,372 | 12 Jun 2025 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 18 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 18:07 |
| GTHX | G1 Therapeutics, Inc. | 18 Sep 2024 | 5 | $0 | 4 | Director | 18 Sep 2024, 16:15 |
| GTHX | G1 Therapeutics, Inc. | 13 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:40 |
| PCVX | Vaxcyte, Inc. | 06 Jun 2024 | 2 | $0 | 4 | Director | 10 Jun 2024, 16:12 |
| PCVX | Vaxcyte, Inc. | 27 Nov 2023 | 1 | $0 | 4 | Director | 29 Nov 2023, 16:49 |
| PCVX | Vaxcyte, Inc. | 27 Nov 2023 | 0 | $0 | 3 | Director | 29 Nov 2023, 16:46 |
| GTHX | G1 Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:06 |
| GTHX | G1 Therapeutics, Inc. | 27 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 17:56 |
| GTHX | G1 Therapeutics, Inc. | 27 Jun 2022 | 0 | $0 | 3 | Director | 29 Jun 2022, 17:54 |